Delivery Order SPE2DB22D3016-SPE2DB25FBHW4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $14,646.60. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $2,652.22. This competitively awarded, firm fixed-price delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 8, 2025. The award represents a routine pharmaceutical supply transaction under a non-set-aside...
- The Defense Logistics Agency awarded a $18,468.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 ml auto-injector units, with a completion date of September 11, 2025. The award was made on September 10, 2025, with no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sumatriptan 6 mg/0.5ml auto-injectors with a ceiling value of $12,080.19. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $2,412.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of July 25, 2025, was awarded on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,572.84 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector supplies. The contract is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and was awarded on July 30, 2025. This award is non-set-aside and represents a competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,914.29 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single procurement action under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units valued at $1,129.39, with an ultimate completion date of August 20, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery contract (IDC) vehicle. The pharmaceutical product will be performed and delivered from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,981.55 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, issued on August 8, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHW4Delivery Order
The Defense Logistics Agency awarded a $11,964.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, which carries an ultimate completion date of September 11, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with an established track record of supplying a comprehensive portfolio of medications and medical supplies through competitive federal procurements. As a major pharmaceutical vendor registered in the System for Award Management, the company supports the Defense Health Agency and other government healthcare entities by providing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for the migraine treatment medication represents a routine execution under the company's broader global pharmaceutical support mission within the DLA supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/10/25 |